168 related articles for article (PubMed ID: 37583846)
1. Safety evaluation of human umbilical cord-mesenchymal stem cells in type 2 diabetes mellitus treatment: A phase 2 clinical trial.
Lian XF; Lu DH; Liu HL; Liu YJ; Yang Y; Lin Y; Xie F; Huang CH; Wu HM; Long AM; Hui CJ; Shi Y; Chen Y; Gao YF; Zhang F
World J Clin Cases; 2023 Jul; 11(21):5083-5096. PubMed ID: 37583846
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and safety of human umbilical cord-mesenchymal stem cells for treating type 2 diabetes mellitus.
Lian XF; Lu DH; Liu HL; Liu YJ; Han XQ; Yang Y; Lin Y; Zeng QX; Huang ZJ; Xie F; Huang CH; Wu HM; Long AM; Deng LP; Zhang F
World J Diabetes; 2022 Oct; 13(10):877-887. PubMed ID: 36312002
[TBL] [Abstract][Full Text] [Related]
3. Melatonin treatment improves human umbilical cord mesenchymal stem cell therapy in a mouse model of type II diabetes mellitus via the PI3K/AKT signaling pathway.
Aierken A; Li B; Liu P; Cheng X; Kou Z; Tan N; Zhang M; Yu S; Shen Q; Du X; Enkhbaatar BB; Zhang J; Zhang R; Wu X; Wang R; He X; Li N; Peng S; Jia W; Wang C; Hua J
Stem Cell Res Ther; 2022 Apr; 13(1):164. PubMed ID: 35414044
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic evidence of umbilical cord-derived mesenchymal stem cell transplantation for cerebral palsy: a randomized, controlled trial.
Gu J; Huang L; Zhang C; Wang Y; Zhang R; Tu Z; Wang H; Zhou X; Xiao Z; Liu Z; Hu X; Ke Z; Wang D; Liu L
Stem Cell Res Ther; 2020 Feb; 11(1):43. PubMed ID: 32014055
[TBL] [Abstract][Full Text] [Related]
5. Human Umbilical Cord Mesenchymal Stromal Cell Treatment of Severe COVID-19 Patients: A 3-Month Follow-Up Study Following Hospital Discharge.
Feng G; Shi L; Huang T; Ji N; Zheng Y; Lin H; Niu C; Wang Y; Li R; Huang M; Chen X; Shu L; Wu M; Deng K; Wei J; Wang X; Cao Y; Yan J
Stem Cells Dev; 2021 Aug; 30(15):773-781. PubMed ID: 34044609
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of umbilical cord tissue-derived mesenchymal stem cells in the treatment of patients with aging frailty: a phase I/II randomized, double-blind, placebo-controlled study.
Zhu Y; Huang C; Zheng L; Li Q; Ge J; Geng S; Zhai M; Chen X; Yuan H; Li Y; Jia W; Sun K; Li Y; Ye T; Zhao Z; Liu H; Liu Z; Jiang H
Stem Cell Res Ther; 2024 Apr; 15(1):122. PubMed ID: 38679727
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic human umbilical cord-derived mesenchymal stem cells for severe bronchopulmonary dysplasia in children: study protocol for a randomized controlled trial (MSC-BPD trial).
Wu X; Xia Y; Zhou O; Song Y; Zhang X; Tian D; Li Q; Shu C; Liu E; Yuan X; He L; Liu C; Li J; Liang X; Yang K; Fu Z; Zou L; Bao L; Dai J
Trials; 2020 Jan; 21(1):125. PubMed ID: 32005282
[TBL] [Abstract][Full Text] [Related]
8. Human Umbilical Cord Mesenchymal Stem Cells to Treat Neuromyelitis Optica Spectrum Disorder (hUC-MSC-NMOSD): A Study Protocol for a Prospective, Multicenter, Randomized, Placebo-Controlled Clinical Trial.
Yao XY; Xie L; Cai Y; Zhang Y; Deng Y; Gao MC; Wang YS; Xu HM; Ding J; Wu YF; Zhao N; Wang Z; Song YY; Wang LP; Xie C; Li ZZ; Wan WB; Lin Y; Jin HF; Wang K; Qiu HY; Zhuang L; Zhou Y; Jin YY; Ni LP; Yan JL; Guo Q; Xue JH; Qian BY; Guan YT
Front Neurol; 2022; 13():860083. PubMed ID: 35547390
[TBL] [Abstract][Full Text] [Related]
9. Preclinical study of human umbilical cord mesenchymal stem cell sheets for the recovery of ischemic heart tissue.
Gao S; Jin Y; Ma J; Wang J; Wang J; Shao Z; Fan T; Zhang M; Chang D
Stem Cell Res Ther; 2022 Jun; 13(1):252. PubMed ID: 35690871
[TBL] [Abstract][Full Text] [Related]
10. Topical and intravenous administration of human umbilical cord mesenchymal stem cells in patients with diabetic foot ulcer and peripheral arterial disease: a phase I pilot study with a 3-year follow-up.
Zhang C; Huang L; Wang X; Zhou X; Zhang X; Li L; Wu J; Kou M; Cai C; Lian Q; Zhou X
Stem Cell Res Ther; 2022 Sep; 13(1):451. PubMed ID: 36064461
[TBL] [Abstract][Full Text] [Related]
11. Subarachnoid transplantation of human umbilical cord mesenchymal stem cell in rodent model with subacute incomplete spinal cord injury: Preclinical safety and efficacy study.
Yang Y; Cao TT; Tian ZM; Gao H; Wen HQ; Pang M; He WJ; Wang NX; Chen YY; Wang Y; Li H; Lin JW; Kang Z; Li MM; Liu B; Rong LM
Exp Cell Res; 2020 Oct; 395(2):112184. PubMed ID: 32707134
[TBL] [Abstract][Full Text] [Related]
12. Intravenous infusion umbilical cord-derived mesenchymal stem cell in primary immune thrombocytopenia: A two-year follow-up.
Wang X; Yin X; Sun W; Bai J; Shen Y; Ao Q; Gu Y; Liu Y
Exp Ther Med; 2017 May; 13(5):2255-2258. PubMed ID: 28565834
[TBL] [Abstract][Full Text] [Related]
13. Preclinical assessments of safety and tumorigenicity of very high doses of allogeneic human umbilical cord mesenchymal stem cells.
Chin SP; Saffery NS; Then KY; Cheong SK
In Vitro Cell Dev Biol Anim; 2024 Mar; 60(3):307-319. PubMed ID: 38421574
[TBL] [Abstract][Full Text] [Related]
14. Liraglutide in combination with human umbilical cord mesenchymal stem cell could improve liver lesions by modulating TLR4/NF-kB inflammatory pathway and oxidative stress in T2DM/NAFLD rats.
Xu X; Wang W; Lin L; Chen P
Tissue Cell; 2020 Oct; 66():101382. PubMed ID: 32933722
[TBL] [Abstract][Full Text] [Related]
15. Human umbilical cord-derived mesenchymal stem cells improve the function of liver in rats with acute-on-chronic liver failure via downregulating Notch and Stat1/Stat3 signaling.
He Y; Guo X; Lan T; Xia J; Wang J; Li B; Peng C; Chen Y; Hu X; Meng Z
Stem Cell Res Ther; 2021 Jul; 12(1):396. PubMed ID: 34256837
[TBL] [Abstract][Full Text] [Related]
16. Effect of hTIMP-1 overexpression in human umbilical cord mesenchymal stem cells on the repair of pancreatic islets in type-1 diabetic mice.
Bao Y; Zhao Z; Gao H
Cell Biol Int; 2021 May; 45(5):1038-1049. PubMed ID: 33404139
[TBL] [Abstract][Full Text] [Related]
17. Curcumin Improves Human Umbilical Cord-Derived Mesenchymal Stem Cell Survival via ERK1/2 Signaling and Promotes Motor Outcomes After Spinal Cord Injury.
Wanjiang W; Xin C; Yaxing C; Jie W; Hongyan Z; Fei N; Chengmin L; Chengjian F; Jichao Y; Jiangkai L
Cell Mol Neurobiol; 2022 May; 42(4):1241-1252. PubMed ID: 33247374
[TBL] [Abstract][Full Text] [Related]
18. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation.
Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C
Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744
[TBL] [Abstract][Full Text] [Related]
19. PTBP-1 and TNF-α/NF-κB are involved in repair mechanisms of human umbilical cord mesenchymal stem cell transplantation in mice with spinal cord injury.
Cao H; Ji X; Wang Q; Guan X; Wei W; Li Y; Zou W; Liu J
Am J Transl Res; 2022; 14(7):4443-4456. PubMed ID: 35958465
[TBL] [Abstract][Full Text] [Related]
20. Effects of single and multiple transplantations of human umbilical cord mesenchymal stem cells on the recovery of ovarian function in the treatment of premature ovarian failure in mice.
Lv X; Guan C; Li Y; Su X; Zhang L; Wang X; Xia HF; Ma X
J Ovarian Res; 2021 Sep; 14(1):119. PubMed ID: 34526090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
